https://vitalspanwire.com/news/slte-1009-pacap-vip-antibody-phase-1-migraineVitalspan Wireen2026-08-28T21:02:11.284ZSlate begins first-in-human test of dual PACAP/VIP antibody for migrainehttps://vitalspanwire.com/news/aficamten-nonobstructive-hcm-phase-3Vitalspan Wireen2026-08-28T16:02:47.012ZAficamten improved function in nonobstructive HCM, with cardiac safety trade-offshttps://vitalspanwire.com/news/centenarian-parentage-delayed-hypertension-cohortsVitalspan Wireen2026-08-28T11:02:34.152ZCentenarian parentage tracks with delayed hypertension across three cohortshttps://vitalspanwire.com/news/australian-retatrutide-products-potency-testingVitalspan Wireen2026-08-27T21:02:03.648ZAustralian Testing Finds Wide Potency Gaps in Products Sold as Retatrutidehttps://vitalspanwire.com/news/fda-brepocitinib-oral-dermatomyositis-approvalVitalspan Wireen2026-08-27T20:47:55.542ZFDA approves brepocitinib as first oral drug for adult dermatomyositishttps://vitalspanwire.com/news/self-contracting-muscle-grafts-aging-miceVitalspan Wireen2026-08-27T20:45:48.811ZSelf-contracting muscle grafts improved strength and metabolism in mice